Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers-Reference-Cited by-同舟云学术

Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers

Published:2016-08 Issue:4 Volume:38 Page:423-431
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Lee Jong W.,Pussegoda Kusala,Rassekh Shahrad R.,Monzon Jose G.,Liu Geoffrey,Hwang Soomi,Bhavsar Amit P.,Pritchard Sheila,Ross Colin J.,Amstutz Ursula,Carleton Bruce C.,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference71 articles.

1. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma;Perilongo;N Engl J Med.,2009

2. Enhancing the efficacy of cisplatin in ovarian cancer treatment—could arsenic have a role;Helm;J Ovarian Res.,2009

3. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects;Hohnloser;Eur J Med Res.,1996

4. US FDA contemplates collection of pharmacogenomic data;Kling;Nat Biotechnol.,2003

5. Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose;Li;Eur J Cancer.,2004

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy;British Journal of Clinical Pharmacology;2024-07-30

2. Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature;Journal of Clinical Oncology;2024-06-20

3. Clinical Predictors of Cisplatin Chemoradiation-Induced Ototoxicity in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study;Journal of Otolaryngology - Head & Neck Surgery;2024-01

4. Pharmacogenomics of Cancer Chemotherapy: Transporter Polymorphisms and Drug Response;Interdisciplinary Cancer Research;2024

5. Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update;Therapeutic Drug Monitoring;2023-07-13